BRCA1 and BRCA2 Somatic Gene Sequencing Panel

The BRCA1 and BRCA2 somatic mutation test on FFPE (Formalin-Fixed Paraffin-Embedded) samples is a molecular diagnostic test that identifies specific mutations in the BRCA1 and BRCA2 genes in tumor tissue. This test utilizes DNA sequencing techniques to analyze the somatic mutations present in the tumor DNA derived from FFPE samples. Detecting somatic mutations in BRCA1 and BRCA2 genes helps in understanding the genetic basis of the tumor and can guide treatment decisions, including targeted therapies and clinical trial eligibility, for individuals with these specific mutations in their tumor tissue.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.